Main menu button

News

Earnings review: Serneke Q1 2017
04 May 2017
Earnings review: Serneke Q1 2017
Equity Research
Earnings comment, TargetEveryone Q1 2017
03 May 2017
Earnings comment, TargetEveryone Q1 2017
Equity Research
Analysis, Kancera: Application filed for clinical trial fas I
03 May 2017
Analysis, Kancera: Application filed for clinical trial fas I
Equity Research
Analysis, Wilson Therapeutics: Rare potential
02 May 2017
Analysis, Wilson Therapeutics: Rare potential
Equity Research
Analysis, FastPartner: Cash at hand creates opportunities
02 May 2017
Analysis, FastPartner: Cash at hand creates opportunities
Equity Research
Analysis, Lammhults: Strong orderbook
28 Apr 2017
Analysis, Lammhults: Strong orderbook
Equity Research
Analysis, Maxkompetens: Acquisition adds value
28 Apr 2017
Analysis, Maxkompetens: Acquisition adds value
Equity Research
Preview, TargetEveryone 2017, Q1
27 Apr 2017
Preview, TargetEveryone 2017, Q1
Equity Research
Preview: Serneke 2017, Q1
21 Apr 2017
Preview: Serneke 2017, Q1
Equity Research
Analysis on TargetEveryone: Value created with new technology
21 Apr 2017
Analysis on TargetEveryone: Value created with new technology
Equity Research
Analysis, Kopy Goldfields: Important results coming up...
11 Apr 2017
Analysis, Kopy Goldfields: Important results coming up...
Equity Research
Eq Research on Xbrane: First delivery to Iran scheduled för march
15 Mar 2017
Eq Research on Xbrane: First delivery to Iran scheduled för march
Equity Research
Interview with Johan Inborr, CEO at Peptonic Medical
15 Mar 2017
Interview with Johan Inborr, CEO at Peptonic Medical
Equity Research
Analysis, Glycorex: Strong organic growth
13 Mar 2017
Analysis, Glycorex: Strong organic growth
Equity Research
Analysis, Gapwaves: Strengthened patents ahead of 5G growth
09 Mar 2017
Analysis, Gapwaves: Strengthened patents ahead of 5G growth
Equity Research
Analysis, VA Automotive: Promising order intake so far in 2017
02 Mar 2017
Analysis, VA Automotive: Promising order intake so far in 2017
Equity Research
Analysis, Fastator: Attractive rebate and building permissions
02 Mar 2017
Analysis, Fastator: Attractive rebate and building permissions
Equity Research
Analysis, MultiDocker: Strong orderbook, thus strong outlook
01 Mar 2017
Analysis, MultiDocker: Strong orderbook, thus strong outlook
Equity Research
Analysis, Amasten: Increasing rebate on increasing value
28 Feb 2017
Analysis, Amasten: Increasing rebate on increasing value
Equity Research
Analysis, FastPartner: Asset value increasing quickly
28 Feb 2017
Analysis, FastPartner: Asset value increasing quickly
Equity Research